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Abstract: This work reports on the design and the synthesis of two short linear peptides 
both containing a few amino acids with disorder propensity and an allylic ester group at the 
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C-terminal end. Their structural properties were firstly analyzed by means of experimental 
techniques in solution such as CD and NMR methods that highlighted peptide flexibility. 
These results were further confirmed by MD simulations that demonstrated the ability of 
the peptides to assume conformational ensembles. They revealed a network of transient 
and dynamic H-bonds and interactions with water molecules. Binding assays with a  
well-known drug-target, i.e., the CXCR4 receptor, were also carried out in an attempt to 
verify their biological function and the possibility to use the assays to develop new specific 
targets for CXCR4. Moreover, our data indicate that these peptides represent useful tools 
for molecular recognition processes in which a flexible conformation is required in order to 
obtain an interaction with a specific target. 
Keywords: intrinsically disordered protein (IDP); intrinsically disordered region (IDR); 
conformational ensemble; MD; NMR; CD; chemokine 
 
1. Introduction 
In the last decade, several proteins with native disordered structure—named Intrinsically Disordered 
Proteins (IDPs)—were reported to be involved in numerous key biological processes, including cell 
cycle control, regulation, signaling and binding events involving biological macromolecules [1–5]. 
Intrinsic disorder depends on the type of amino acids composing a certain protein [6–8]. The structural 
plasticity of proteins is mainly induced by the presence of residues inherently flexible, polar and 
charged. Through inherent flexibility, the mentioned residues have the ability to recognize different 
ligands, including other proteins, membranes, and nucleic acids [8]. Further studies have also shown 
that a flexible intrinsically disordered region (IDR) in a given protein can fold in several ways as a 
consequence of its binding to distinct partners. Moreover, the residue flexibility may also allow 
different protein sequences to recognize the same binding site on a specific partner [9]. Often, IDPs or 
IDRs are critically involved in receptor signaling, where they modulate the native and functional state 
of many proteins [10]. However, there is a limit to the understanding of the molecular mechanisms that 
regulate biological functions in which IDPs are involved: there is a lack of knowledge about the 
physical basis on which these processes rely [11]. Recently, authors have demonstrated that each IDP 
dynamically explores an ensemble of unfolded configurations, then each IDP assumes more stable and 
ordered structures after binding to their ligands is complete [12,13]. Molecular dynamics (MD) 
simulations can provide useful information about these issues in the spatio-temporal resolution. In fact, 
the flexibility of a protein can be derived from the trajectory of a MD simulation by calculating the 
root mean-squared fluctuations (RMSFs) of single atoms after removing the translational and 
rotational movements. Vibrations around equilibrium are not random but depend on local structure 
flexibility. Hence, RMSFs capture the fluctuation of each atom around average positions. Usually, the 
analysis of the average atomic mobility of backbone atoms (N, Cα and C atoms) during MD simulation 
gives insight into the flexible and rigid regions of proteins [14]. 
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In this paper we designed short peptides as IDRs model systems in order to better understand 
molecular recognition processes involving IDPs. In particular, we focused on the two following 
synthetic linear peptides: PepK: Y-G-E-C-P-C-K-OAllyl; PepE: Y-G-E-C-P-C-E-OAllyl. 
Both these peptides were designed by choosing a few residues with disorder propensity. At the  
C-termini of PepK and PepE a Lys and Glu residues were added, respectively, aiming to study the 
effect of charges in modulating the binding properties on a general target. The reactive allylic ester group 
was added to easily allow further chemical modifications finalized to improve biological activities. 
The conformational behavior of the two peptides was firstly analyzed by CD (Circular Dichroism) 
and 1D [1H] and 2D [1H, 1H] NMR (Nuclear Magnetic Resonance) spectroscopies in order to establish 
their high flexibility and their inability to adopt a single ordered conformation. In addition, MD simulations 
indicated that the two peptides could be adequately represented by conformational ensembles. 
In an attempt to define a biological significance for the above mentioned peptides, we have 
investigated their role as interactors of a known drug-target, i.e., the CXCR4 receptor. Its 
overexpression results in metastatic dissemination of breast cancer cells to the lungs and lymph nodes 
and they contribute to melanoma tumor cell dissemination selectively to the lungs but not to the  
lymph nodes [15,16]. Moreover, CXCR4 has also been found to be a prognostic marker in multiple 
cancers including melanoma, colon cancer, leukemia, breast cancer, and gliomas [15,16]. Therefore, as 
CXCR4 is overexpressed in several human cancers, the blockade of CXCR4–CXCL12 interaction has 
been extensively investigated as a potential cancer therapeutic. Recently, we designed and synthesized 
two short flexible peptides, they both possess a CPC motif. Then we analyzed their structure by means 
of experimental and computational methods. Finally, we evaluated their interaction with CXCR4 by 
means of in vitro studies at 1 and 10 µM concentrations [15]. 
Hence, in this work we carried out biological tests to evaluate if PepE and PepK were able to:  
(i) interact with the CXCR4 receptor; (ii) inhibit CXCL12-induced migration; and (iii) reduce cAMP 
(Cyclic Adenosine Monophosphate) levels. Our data pointed out that PepE and PepK target the 
CXCR4 receptor by modulating the adenylate cyclase and they represent the starting point to design 
useful “instruments” for molecular recognition processes in which a flexible conformation is needed 
for the interaction with a specific target. 
2. Results and Discussion 
The two linear intrinsically disordered peptides PepK and PepE have been designed choosing a few 
amino acids with disorder propensity. A Lys residue has been added at C-terminal side of PepK and a 
Glu residue has been added at the C-terminal side of PepE. The conformational features of both 
peptides were studied in solution by CD, NMR and MD techniques. 
2.1. Circular Dichroism 
The secondary structure of PepE and PepK in PBS was studied by circular dichroism (CD) 
spectroscopy and analyzed by the CAPITO web server (http://capito.nmr.fli-leibniz.de). As expected 
for very short peptide sequences, both peptides did not show any tendency to fold under this 
experimental condition [17]. CD spectra (Figure 1) show a typical shape of an unordered structure with 
a negative band between 197 and 201 nm. This behavior is also confirmed by CAPITO analysis [18], 
 
Int. J. Mol. Sci. 2015, 16 12162 
 
where spectra values—such as mean residue ellipticity (θ)—at λ = 200 nm are plotted versus  
λ = 222 nm. In fact, both the peptides are located in unfolded regions. It is important to notice that the 
CD spectrum of PepK presents also a maximum centered at 225 nm that has been already associated to 
the presence of fluctuating Polyproline II (PII) helices by various authors in recent papers [13,19,20]. 
 
Figure 1. CD spectra of PepK and PepE (upper panel) and CD analysis by CAPITO tool 
(lower panel) where both peptides are indicated as unfolded peptides. 
2.2. NMR Characterization 
In aqueous solution, the poor spectral dispersion of the 1D [1H] spectra and the almost complete 
absence of signal in the 2D [1H, 1H] NOESY [21] experiments indicated that both peptides were very 
flexible (data not shown). However, complete proton resonance assignments were achieved by 
combined analysis of the 2D [1H, 1H] TOCSY [22] and ROESY [23] spectra (Figures 2 and 3;  
Tables S1 and S2). 
Moreover, we evaluated chemical shifts deviations of Hα protons from random coil values  
(Tables S3 and S4), which resulted in prevalence small and positive and characteristic of an extended 
disordered conformation [24]. The disorder state of both peptides was further strengthened by ROE 
patterns (Figure S1) which showed strong and sequential Hαi–HNi+1 contacts typical of flexible 
peptides [25]. Due to the proximity of chemical shifts between Cys4 Hα proton and water in both PepE 
and PepK, we could not clearly identify the configuration (i.e., cis or trans) of the Cys4–Pro5  
peptide bond. 
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Figure 2. Comparison of 2D [1H, 1H] TOCSY (left) and ROESY (right) spectra of PepE 
in H2O/D2O (90/10). The HN-aliphatic protons correlation regions are shown in each panel; 
spin system assignments are indicated in the left side. In the right panel, sequential ROE 
contacts are highlighted by rectangles and the corresponding assignments are indicated. 
 
Figure 3. Comparison of 2D [1H, 1H] TOCSY (left) and ROESY 200 (right) spectra of 
PepK in H2O/D2O (90/10). The two sides of the figure show spectral regions containing 
HN/aliphatic protons correlations; spin system assignments are indicated in the TOCSY left 
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2.3. Molecular Dynamics Simulations on the Two Peptides 
Molecular dynamics simulations were performed on the two peptides, which were linearly modeled 
as reported in the Material and Methods Section, at neutral pH. In Figure 4A, we show the plots of  
the Root Mean Square Deviation (RMSD), computed by overlapping the various structures during 
simulations in respect to the initial conformation. RMSD plots of PepK and PepE evidence high levels 
of fluctuation, thus suggesting that these peptides are flexible. On the one hand, this result is confirmed 
also by Root Mean Square Fluctuation (RMSF) plots where the residues located at N- and C-termini 
present higher values of RMSF (Figure 4B). Instead, the gyration radii decreased during the simulations 
(Figure 4C) reaching a value of 0.5 nm. This suggests an increasing compactness of the two peptides, 
which result as if they were stabilized by a certain number of H-bonds of main chain–main chain 
(MM), main chain–side chain (MS) and side chain–side chain (SS) types (Figure 4D). For this reason, 
the two peptides tended to become more compact and the radius of gyration decreased. According to 
the data obtained by CD and NMR measurements in aqueous solution, the analysis of the secondary 
structure evolution clearly showed the high flexibility of both peptides during the simulations, which 
makes difficult the formation of stable regular secondary structure elements, i.e., helix and β-strand. 
Very flexible peptide structure are normally characterized by several conformers at equilibrium, hence 
they could be well described by a conformational ensemble. Having taken this property into proper 
account, we have firstly performed a cluster analysis to determine the groups of structures that share 
similar conformational features according to their RMSD values. 
 
Figure 4. Analysis of the molecular dynamics simulations performed on PepE (in black) 
and PepK (in grey) at physiological pH in explicit solvent in terms of: (A) root mean 
square deviation (RMSD) plot; (B) root mean square fluctuation (RMSF); (C) gyration 
radius plot; and (D) H-bonds plot. 
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The number of the most populated clusters resulted as equal to 8 for PepE and 9 for PepK. These 
clusters are mainly stabilized by MM H-bonds (Figure 5) that involved the atomic groups of the 
peptide backbone. This structural organization was observed by Pappu et al. [26] for charged peptides: 
it closely resembles the organization of collapsed and slightly soluble globules. 
Since CD spectra of PepK pointed out the presence of PII, we verified its possible occurrence in the 
most populated clusters by using the angular ranges following reference parameters for the angles: 
−110° ≤ φ ≤ −40° and 130° ≤ ψ ≤ 180° in the Ramachandran map [27]. No residues in PII were present 
in eight clusters of PepE whereas in 5 out of 9 clusters of PepK we identified residues in PII (Figure S2), 
according to CD analysis. 
It is well known that the peptide dynamics depend on the surrounding solvent, which mediates 
interactions among residues. Therefore, we have analyzed the total number of water molecules in the 
system and their possible role [28]: the simulation box for PepE and PepK contained 2956 and 2611 
water molecules, respectively. The total average number of water molecules that formed H-bonds 
resulted slightly higher for PepE if compared to PepK: 33 and 30 in PepE and PepK, respectively. This 
trend could be due to the different amino acid sequence of the two peptides; in fact PepK has got two 
oppositely charged residues in 3 and 7 positions, hence it may assume a more compact structure. The 
majority of H-bonds (indicatively 60%) for both peptides resulted to involve the peptide backbone, 
being of main chain—water oxygen type (MH) or of the water oxygen and main chain type (HM).  
A detailed analysis of the residues involved in H-bonds with water molecules pointed out that the 
residues in positions 1, 3 and 7 (Y, E and E in PepE and Y, E and K in PepK) have developed a higher 
number of H-bonds with water molecules than the residues located in the other four positions (Table S5). 
Furthermore, the average number of H-bonds developed by E and K with water molecules was lower 
than the average number of the H-bonds developed by E and E with water molecules in PepE. Hence, 
these results confirmed that PepE tended to assume more extended conformations being that it contains 
two negatively charged residues that could allow large interactions with water molecules. 
Generally, the data evidence that the structure of both peptides is very flexible, and can be 
dynamically stabilized by a network of MM H-bonds. Hence, their structures can be adequately 
represented as conformational ensembles characterized by fluctuating irregular secondary structures. In 
fact, the peptides do not assume stable and fixed conformations: they go continuously from one cluster 
to another. As the high flexibility of peptides did not allow us to calculate a 3D model based on NMR 
parameters, the MD was very useful to understand how these peptides can move as well as to 
understand that the best conformers needed to be put together to have a clear representation. In 
particular, the two peptides do not explore the full space, but rather, the rapid interchange among the 
flexible conformers induce quick changes between clusters. This is in line with the data shown in 
Figure 4B where it is visible that the more flexible residues are located in the terminal ends. 
 






Figure 5. The map of MM H-bonds in the 8 and 9 clusters calculated for the PepE (A) and 
PepK (B), respectively, during MD simulations. We reported with the same colors the 
residues involved in the same MM H-bonds. 
2.4. Functional Characterization on CXCR4 Receptor 
We have designed a short disordered peptide the containing CPC motif and we have analyzed  
its binding capability on the CXCR4 receptor finding a behavior as ligand [15]. Hence, we performed 
PepK and PepE functional characterization on the same chemokine receptor. In order to assess the 
inhibitory capability of PepK and PepE on CXCR4 function, we have evaluated peptides binding to  
the receptor through an indirect binding assay; then, in addition we have assessed the inhibition of 
CXCL12-induced migration and evaluated the activity of the adenylate cyclase function. The results 
were compared to Plerixafor (known as AMD3100) that is used as a clinical antagonist of CXCR4. 
The treatment with plerixafor plus Granulocyte-colony stimulating factor (G-CSF) induced the 
mobilization of hematopoietic precursors from bone marrow, allowing a more efficient recovery of the 
CD34 stem cells necessary for autologous stem cell transplantation [29]. 
The binding of the two peptides to CXCR4 was evaluated in CCRF-CEM cells using a CXCR4 
12G5 monoclonal antibody as previously described [30]. PepK and PepE were evaluated at concentrations 
similar to the peptidic antagonists recently developed [16,30]. Indeed, we have tested only two peptide 
concentrations (1 and 10 µM), which are matching the ones previously used in CXCR4 binding assays. 
As shown in Figure S3, PepK and PepE did not displace the 12G5 antibody compared to AMD3100, 
which strongly reduced antibody binding to CXCR4 (Figure S3). These results may be explained 
considering the different binding sites on AMD3100/12G5 antibody and the high flexibility of the two 
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disordered peptides. Moreover, cAMP and migration assays were carried out as well in order to 
evaluate the peptide ability to inhibit the activation of CXCR4 mediated intracellular pathways. 
CXCR4 is a G-Protein coupled receptor, which, as result of the binding to CXCL12, inhibits 
through the G-protein the adenylate cyclase activity and the inhibition of cAMP production as “second 
messenger” [31]. In Figure S4, preliminary biological results are summarized. The results underline 
that in the presence of CXCL12 (100 ng/mL) and Forskolin (1 µM): (i) PepE determines a dose 
dependent increase of the cAMP level of 20% at the lower dose (1 μM) and 65% at the higher dose  
(10 μM); (ii) PepK increases cAMP but the effect is not dose-dependent; and (iii) AMD3100 has 
activities comparable or even less efficient than PepE. Hence, PepK and PepE result to modulate the 
adenylate cyclase at equal or higher levels as AMD3100. 
Finally, the migration was performed (Figure S5) and, both PepK and PepE reduced CCRF-CEM 
cells migration towards CXCL12 although less effectively than AMD3100. In particular, PepE reduces 
the migration index from 1.75- to 1.35-fold and PepK from 1.75- to 1.55-fold, whereas AMD3100 
from 1.75- to 1.15-fold. 
3. Experimental Section 
Protected fluorenylmethoxycarbonyl (Fmoc)Nα-Fmoc-amino acid derivatives, 2-chlorotrityl chloride 
resin pre-loaded with Fmoc-Glu-OAllyl and Fmoc-Lys-OAllyl and coupling reagents were purchased 
from Novabiochem (Schwalbach, Germany) and Iris Biotech GMBH (Marktredwitz, Germany). All 
other chemicals were commercially available by Sigma–Aldrich (Milwaukee, WI, USA) and Acros 
(Geel, Belgium). The purity of products was determined by analytic reverse-phase HPLC using a 
VWR Hitachi instrument (Radnor, PA, USA) equipped with a L-2450 auto sampler, two L-2130 
pumps, a Satisfaction RP18-AE column (5 μm, 250 × 4.6 mm) and a L-2450 diode array detector, at  
a flow rate of 0.8 mL/min. 
The compounds were purified by preparative reverse-phase HPLC using a VWR LaPrep system 
consisted of a P202 injector, two P110 pumps, a Satisfaction RP18-AB C18 column (5 μm, 250 × 20 mm) 
and a P314 UV detector, at a flow rate of 10 mL/min. 
The following eluents were used in a gradient mode: (A) 0.1% trifluoroacetic acid (TFA) in 
H2O/CH3CN (95/5) and (B) 0.1% TFA in CH3CN/H2O (95/5). Water was of Milli-Q quality and was 
obtained after filtration of distilled water through a Milli-Q® cartridge system (Millipore Co., Billerica, 
MA, USA). CH3CN and TFA were of HPLC use quality. Degassing of solvents was performed using 
argon bubbling. Gradient used for the analytic and preparative RP-HPLC was respectively from  
0% B to 100% B in 15 min and from 0% to 70% B in 70 min; UV detection at 214 nm. CH3CN was 
evaporated and the aqueous solution was freeze-dried to give purified PepK and PepE as white solids 
(68% and 54% yield, respectively). 
Peptide identity was confirmed by mass spectrometry analyses performed on an Ultraflex III 
TOF/TOF system (Bruker Daltonics, Bremen, Germany), equipped with 200 Hz smart beam laser  
(355 nm) and operating in reflectron positive ion mode. Mass spectra were acquired over the m/z range 
450–5000 by accumulating data from 1000 laser shots for each spectrum. The instrumental conditions 
employed to analyze molecular species were the following: ion source 1: 25.08 kV; ion source 2: 21.98 kV, 
lens: 11.03 kV, pulsed ion extraction: 30 ns, reflector: 26.39 kV, reflector 2: 13.79 kV. Matrix 
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suppression was activated by deflection mode: suppression up to 450 Da. Mass calibration was 
performed for each samples in range of ~700–3200 Da with a peptide calibration mixture (8206195, 
Peptide Calibration Standard, Bruker Daltonics). The instrument was controlled using Bruker’s 
flexControl 3.4 software and mass spectra were analyzed in Bruker’s FlexAnalysis 3.4 software. 
3.1. Synthesis 
PepK (sequence: YGECPCK-OAllyl) and PepE (sequence: YGECPCK-OAllyl) were synthesized 
by Fmoc standard chemistry protocol on 2-chlorotrityl chloride resin pre-loaded with the side chain of 
a Fmoc-Lys-OAllyl and a Fmoc-Glu-OAllyl, respectively (0.24 mmol scale). 
Swelling and Fmoc-deprotection: Swelling and Fmoc-deprotection steps were performed by treating 
the resin for 30 min in dichlorometane (DCM) and in dimethylformamide (DMF)/Piperidine (Pip) 
(80/20, v/v) solution, respectively. 
Washing: Washing steps after coupling and deprotection steps were performed by treating resin in 
DMF (3 × 1 min), MeOH (1 × 1 min), and DCM (3 × 1 min), successively. 
Amino acid coupling: The resin was immersed and mixed in a DMF solution containing the  
Fmoc-protected amino acid (3 eq), O-benzotriazole-tetramethyl-uronium-hexafluoro-phosphate (HBTU) 
(3 eq), and diisopropylethylamine (DIEA) (6 eq) for 2 h at room temperature. 
Peptide cleavage: The peptide was cleaved by immersing the resin in TFA/H2O/triisopropylsilane 
(TIS) (30 mL, 95/2.5/2.5, v/v/v) for 3 h. The cleavage cocktail was filtered from the resin, peptides 
were precipitated with ice-cold diethyl ether, centrifuged, and decanted. Precipitation, centrifugation, 
and decantation operations were repeated twice. The resulting white solid was dissolved in water  
(10 mL) and freeze-dried to give a white powder that was analyzed for purity and purified by 
preparative RP-HPLC, using the specified conditions. 
3.2. Circular Dichroism Measurement 
Far-UV CD spectra were recorded from 190 to 260 nm on a Jasco J-810 spectropolarimeter 
(JASCO Inc., Easton, MD, USA) equipped with a NesLab RTE111 thermal controller unit using  
a 1 mm quartz cell at 25 °C. Circular dichroism measurements were carried out on lyophilized  
peptides dissolved in 10 mM phosphate buffer at pH 7.4 M at a peptide concentration of 5 × 10−6 M. 
Other experimental settings were: scan speed, 10 nm·min−1; sensitivity, 50 mdeg; time constant,  
16 s; bandwidth, 1 nm. Each spectrum was obtained averaging three scans, and by subtracting 
contributions from other species in solution and converting the signal to mean residue ellipticity in 
units of deg·cm2·dmol−1·res−1. 
3.3. NMR Analysis 
NMR spectra were recorded at 25 °C on a Varian Unity Inova 600 MHz spectrometer (Varian Inc., 
Palo Alto, CA, USA) provided with a cold probe. The process of proton resonance assignments was 
carried out with a canonical protocol [25] based on analysis of the following two dimensional [1H, 1H] 
spectra: TOCSY (Total Correlation Spectroscopy) (70 ms mixing time) [22], DQFCOSY (Double 
Quantum Filter Correlation Spectroscopy) [32], NOESY (Nuclear Overhauser Enhancement 
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Spectroscopy) [21] (300 ms mixing time) and ROESY (Rotating frame Overhauser Enhancement 
Spectroscopy) [23] (200 ms mixing time). Chemical shifts were referenced with respect to the TSP 
(trimethylsilyl-3-propionic acid sodium salt-d4, 99% d, (Armar Scientific, Döttingen, Switzerland) 
signal at 0.0 ppm. 
1D spectra were acquired with a relaxation delay of 1 s and 32–128 scans. 2D experiments were 
generally acquired with 32–64 scans, 128–256 FIDs in t1, 1024 or 2048 data points in t2. The DPFGSE 
(Double Pulsed Field Gradient Selective Echo) sequence [33] was used to suppress water signal. 
Spectra were processed with the Varian software VNMRJ 1.1D (Varian by Agilent Technologies, 
Milan, Italy) and analyzed with the NEASY [34] program that is included in the CARA (Computer 
Aided Resonance Assignment) software package (http://www.nmr.ch/). 
3.4. Molecular Modeling and Dynamics Simulations 
PepK and PepE have been built by using the Builder module in InsightII and then subjected to 
molecular dynamics (MD) simulations performed with the GROMACS software package (v3.3.1) [35]. 
In detail, each peptide was put in a cubic box filled with SPC216 water molecules, and GROMOS43a1 
was selected as force field because it is commonly used as force field for MD simulations on peptides 
and our group has already used it in other previous papers in which we reported some conformational 
studies on different peptides where the results obtained from MD simulations proved to be in excellent 
agreement with CD and/or NMR studies [13,15,16]. In order to optimize the systems, the peptides 
were previously subjected to energy minimization and position restraints cycles. The simulations were 
carried out with periodic boundary conditions by adding chloride ions so that the net electrostatic 
charge of the system was zero. The bond lengths were constrained by the linear constraint solver 
algorithm. Particle mesh Ewald algorithm was used for the electrostatic interactions with a cutoff of 
0.9 nm, according to our recent papers [13,15,36]. All simulations were run for 20 ns at neutral pH and 
room temperature (300 K) coupling to the system an external bath. GROMACS routines RMSD and 
RMSF, gyration radius, number of H-bonds and secondary structure evolution were utilized to check 
the trajectories and the quality of the simulations. Additionally, on the basis of the distances between 
structures, like RMSD values, we founded a set of clusters that reflects the range of conformations 
accessible and the relative weight of each of these by using a clustering algorithm implemented in 
GROMACS as reported also in our recent papers [13,16]. The presence of putative H-bonds between 
the residues and with water molecules was evaluated by Hbplus [37]. 
3.5. Migration Assay 
CCRF-CEM cells migration was assayed in 24-well Transwell chambers (Corning Inc., Corning, 
NY, USA) using inserts with an 8-μm pore membrane. Membranes were precoated with collagen 
(human collagen type I/III) and fibronectin (20 mg/mL each). CCRF-CEM cells were placed in the 
upper chamber (1 × 105 cells/well) in RPMI containing 1% BSA (migration media). Cells were  
pre-incubated for 45 min with CXCR4 antagonist and allowed to migrate toward 100 ng/mL CXCL12 
in the lower chamber. After 16 h incubation, migrated cells were collected from the lower chamber and 
counted. The migration index was defined as the ratio between migrating cells in the experimental 
group and migrated cells in the control group. 
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3.6. Binding Assay 
PepK and PepE binding to CXCR4 was evaluatedas previously described [30]. Briefly 2.5 × 105 
CCRF–CEM cells were pre-incubated with 10 μM antagonist peptides in binding buffer (PBS 1× plus 
0.2% BSA and 0.1% NaN3) for 1 h at 37 °C, 5% CO2 and then labeled for 45 min with anti-CXCR4 
PE-antibody (FAB170P, clone 12G5, R&D Systems, Minneapolis, MN, USA). Cells were washed in 
PBS and analyzed by FACS Canto II cytofluorimeter (Becton Dickinson Immunocytometry Systems, 
Mountain View, CA, USA). 
3.7. cAMP Assay 
CCRF-CEM cells (1 × 106) were incubated in presence of PepK, PepE or Plerixafor (known as 
AMD3100) being a CXCR4 antagonist that has provided proof of concept for inhibition of the 
pathway [31] at different concentrations (1 and 10 μM) in combination with forskolin (F) (1 μM) for 
20 min, followed by stimulation with CXCL12 (100 ng/mL) for 10 min. Controls include cells 
stimulated with CXCL12 and forskolin or forskolin alone in absence of anti-CXCR4 inhibitors. Cells are 
harvested and lysed with 0.1 M HCl and cAMP levels was assayed using a direct competitive enzyme 
immunoassay (BioVision Incorporated, Milpitas, CA, USA) according to manufacture instructions. 
4. Conclusions 
As CXCR4 is overexpressed in several human cancers, the blockade of CXCR4–CXCL12 
interaction represents from many years an interesting drug-target [15]. Moreover, the plerixafor 
(previously known as AMD3100) is the most clinically advanced compound even if it showed 
cardiotoxicity, as reported in its clinical trial against HIV [38]. Therefore, this suggests the need to 
develop new antagonists able to block, without any other compliance, the binding between CXCL12 
and CXCR4. In this work we have described the structural preferences in solution of two synthetic 
linear peptides containing a few amino acids with disorder propensity, and an allylic ester group at the 
C-terminal end. NMR and CD solution studies, revealed the absence of regular secondary structure 
elements thus confirming the natively disordered nature of these peptides. MD simulations evidenced 
that, even if they are flexible, they are stabilized by a network of transient and dynamic intra-molecular 
H-bonds of MM type and by interactions with water molecules. In details, NMR and computational 
studies showed the flexibility of PepE and PepK, their inability to adopt a single ordered conformation 
and, hence, the need to represent them by conformational ensembles characterized by the presence of 
transient and dynamic MM H-bonds. 
Moreover, we have performed a functional characterization of the two peptides by investigating  
(a) their ability to interact with the CXCR4 receptor; (b) the inhibition of CXCL12-induced migration 
and (c) the reduction of cAMP levels. Generally, we pointed out that PepK and PepE result to modulate 
the adenylate cyclase as much or more as AMD3100, i.e., the best characterized CXCR4 inhibitor. 
These results indicate that the short flexible peptides could efficiently target the CXCR4 receptor. 
This preliminary evidence suggests that the PepK and PepE interact with CXCR4 and they 
represent a potential starting system able to be converted to more efficient in vitro and in vivo 
antagonists of CXCR4. 
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